JP2016199578A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016199578A5 JP2016199578A5 JP2016135208A JP2016135208A JP2016199578A5 JP 2016199578 A5 JP2016199578 A5 JP 2016199578A5 JP 2016135208 A JP2016135208 A JP 2016135208A JP 2016135208 A JP2016135208 A JP 2016135208A JP 2016199578 A5 JP2016199578 A5 JP 2016199578A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- compound
- composition according
- subject
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 18
- 150000001875 compounds Chemical class 0.000 claims 13
- 208000024891 symptom Diseases 0.000 claims 6
- 201000000980 schizophrenia Diseases 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 4
- 239000012453 solvate Substances 0.000 claims 4
- 208000007848 Alcoholism Diseases 0.000 claims 2
- 208000019901 Anxiety disease Diseases 0.000 claims 2
- 208000001613 Gambling Diseases 0.000 claims 2
- 208000004547 Hallucinations Diseases 0.000 claims 2
- 206010021567 Impulsive behaviour Diseases 0.000 claims 2
- 201000007930 alcohol dependence Diseases 0.000 claims 2
- 230000036506 anxiety Effects 0.000 claims 2
- 239000003693 atypical antipsychotic agent Substances 0.000 claims 2
- 229940127236 atypical antipsychotics Drugs 0.000 claims 2
- 230000001771 impaired effect Effects 0.000 claims 2
- 230000036651 mood Effects 0.000 claims 2
- 208000027776 Extrapyramidal disease Diseases 0.000 claims 1
- 206010060891 General symptom Diseases 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 231100000870 cognitive problem Toxicity 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- RNRYULFRLCBRQS-UHFFFAOYSA-N O=C(CN1CCC(CN(Cc2ccccc22)C2=O)CC1)c(cc1)ccc1F Chemical compound O=C(CN1CCC(CN(Cc2ccccc22)C2=O)CC1)c(cc1)ccc1F RNRYULFRLCBRQS-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36608010P | 2010-07-20 | 2010-07-20 | |
| US61/366,080 | 2010-07-20 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013520841A Division JP2013531073A (ja) | 2010-07-20 | 2011-07-20 | シグマ受容体に仲介される障害を処置するための環状アミド誘導体の使用の方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017225061A Division JP6419294B2 (ja) | 2010-07-20 | 2017-11-22 | シグマ受容体に仲介される障害を処置するための環状アミド誘導体の使用の方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016199578A JP2016199578A (ja) | 2016-12-01 |
| JP2016199578A5 true JP2016199578A5 (enExample) | 2017-03-02 |
Family
ID=45497167
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013520841A Pending JP2013531073A (ja) | 2010-07-20 | 2011-07-20 | シグマ受容体に仲介される障害を処置するための環状アミド誘導体の使用の方法 |
| JP2016135208A Pending JP2016199578A (ja) | 2010-07-20 | 2016-07-07 | シグマ受容体に仲介される障害を処置するための環状アミド誘導体の使用の方法 |
| JP2017225061A Active JP6419294B2 (ja) | 2010-07-20 | 2017-11-22 | シグマ受容体に仲介される障害を処置するための環状アミド誘導体の使用の方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013520841A Pending JP2013531073A (ja) | 2010-07-20 | 2011-07-20 | シグマ受容体に仲介される障害を処置するための環状アミド誘導体の使用の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017225061A Active JP6419294B2 (ja) | 2010-07-20 | 2017-11-22 | シグマ受容体に仲介される障害を処置するための環状アミド誘導体の使用の方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US20130274290A1 (enExample) |
| EP (2) | EP4070794A3 (enExample) |
| JP (3) | JP2013531073A (enExample) |
| KR (1) | KR101867634B1 (enExample) |
| CN (2) | CN103108548A (enExample) |
| BR (1) | BR112013001302A2 (enExample) |
| CA (2) | CA3154027A1 (enExample) |
| DK (1) | DK2595485T3 (enExample) |
| ES (1) | ES2914120T3 (enExample) |
| HU (1) | HUE058736T2 (enExample) |
| PL (1) | PL2595485T3 (enExample) |
| PT (1) | PT2595485T (enExample) |
| RU (2) | RU2746871C2 (enExample) |
| TW (1) | TWI520949B (enExample) |
| WO (1) | WO2012012543A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8937900B2 (en) | 2010-07-20 | 2015-01-20 | Qualcomm Incorporated | Enhancing pilot channel transmission in TD-SCDMA multicarrier systems using secondary carrier frequencies |
| US10179776B2 (en) | 2014-06-09 | 2019-01-15 | Intra-Cellular Therapies, Inc. | Compounds and methods of use to treat schizophrenia |
| ES2910528T3 (es) * | 2014-12-02 | 2022-05-12 | Minerva Neurosciences Inc | Composiciones que comprenden 2-((1-(2(4-fluorofenil)-2-oxoetil)piperidin-4-il)metil)isoindolin-1-ona para tratar la esquizofrenia |
| EP3463356A1 (en) * | 2016-05-25 | 2019-04-10 | Minerva Neurosciences, Inc. | Compositions and methods for treating negative symptoms in non-schizophrenic patients |
| EP3641732A1 (en) * | 2017-06-21 | 2020-04-29 | Minerva Neurosciences, Inc. | Gastro-resistant controlled release oral dosage forms |
| BR112021002654A2 (pt) * | 2018-08-21 | 2021-05-04 | Minerva Neurosciences, Inc. | uso de roluperidona para tratar sintomas e distúrbios negativos, aumentar a neuroplasticidade e promover neuroproteção |
| IL298323B2 (en) | 2020-05-20 | 2023-10-01 | Univ Illinois | A method for treating lysosomal storage disease using histatin peptides |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE903857A1 (en) * | 1989-10-27 | 1991-05-08 | Du Pont Merck Pharma | (N-Phthalimidoalkyl)Piperidines |
| KR927002347A (ko) * | 1989-10-27 | 1992-09-03 | 레이몬드 지. 아너 | (n-프탈이미도알킬) 피페리딘 |
| KR100259107B1 (ko) * | 1992-04-23 | 2000-07-01 | 슈테펜 엘. 네스비트 | 세로토닌 5ht₂길항제로서의 4-이미도메틸-1-[2'-페닐-2'-옥소에틸]피페리딘, 이의 제조방법 및 이를 포함하는 약제학적 조성물 |
| DE60129210T2 (de) * | 2000-02-29 | 2008-03-20 | Mitsubishi Pharma Corp. | Zyklische amid-derivate |
| TW200817400A (en) * | 2006-05-30 | 2008-04-16 | Elbion Ag | Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them |
-
2011
- 2011-07-20 ES ES11810350T patent/ES2914120T3/es active Active
- 2011-07-20 DK DK11810350.6T patent/DK2595485T3/da active
- 2011-07-20 PT PT118103506T patent/PT2595485T/pt unknown
- 2011-07-20 RU RU2017105262A patent/RU2746871C2/ru active
- 2011-07-20 PL PL11810350T patent/PL2595485T3/pl unknown
- 2011-07-20 CA CA3154027A patent/CA3154027A1/en active Pending
- 2011-07-20 WO PCT/US2011/044698 patent/WO2012012543A1/en not_active Ceased
- 2011-07-20 TW TW100125662A patent/TWI520949B/zh active
- 2011-07-20 BR BR112013001302A patent/BR112013001302A2/pt not_active Application Discontinuation
- 2011-07-20 CN CN2011800450188A patent/CN103108548A/zh active Pending
- 2011-07-20 RU RU2013107378A patent/RU2613201C2/ru active
- 2011-07-20 US US13/810,775 patent/US20130274290A1/en not_active Abandoned
- 2011-07-20 JP JP2013520841A patent/JP2013531073A/ja active Pending
- 2011-07-20 CA CA2805904A patent/CA2805904C/en active Active
- 2011-07-20 EP EP22162273.1A patent/EP4070794A3/en active Pending
- 2011-07-20 HU HUE11810350A patent/HUE058736T2/hu unknown
- 2011-07-20 EP EP11810350.6A patent/EP2595485B1/en active Active
- 2011-07-20 KR KR1020137004218A patent/KR101867634B1/ko active Active
- 2011-07-20 CN CN201611063838.0A patent/CN107007603A/zh active Pending
-
2016
- 2016-05-24 US US15/163,385 patent/US20160354357A1/en not_active Abandoned
- 2016-07-07 JP JP2016135208A patent/JP2016199578A/ja active Pending
-
2017
- 2017-11-22 JP JP2017225061A patent/JP6419294B2/ja active Active
-
2020
- 2020-06-29 US US16/914,862 patent/US20210106573A1/en not_active Abandoned
-
2025
- 2025-01-15 US US19/021,774 patent/US20250228838A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016199578A5 (enExample) | ||
| JP2018065829A5 (enExample) | ||
| JP2015505564A5 (enExample) | ||
| JP2018193377A5 (enExample) | ||
| JP2018021046A5 (enExample) | ||
| PH12015502691A1 (en) | Use of high dose pridopidine for treating huntington's disease | |
| JP2018529742A5 (enExample) | ||
| JP2012193216A5 (enExample) | ||
| JP2006104221A5 (enExample) | ||
| JP2017531033A5 (enExample) | ||
| JP2016508134A5 (enExample) | ||
| JP2016014070A5 (enExample) | ||
| JP2016528162A5 (enExample) | ||
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| JP2015511609A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| RU2013150861A (ru) | Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний | |
| JP2015510916A5 (enExample) | ||
| SI2889033T1 (en) | Treatment of negative symptoms of schizophrenia with (R) -7-chloro-N- (chonylidin-3-yl) benzo (B) thiophene-2-carboxamide and pharmaceutically acceptable salts thereof | |
| JP2019535760A5 (ja) | ガボキサドールを用いた注意欠陥多動性障害（ａｄｈｄ）の治療方法 | |
| JP2020529995A5 (enExample) | ||
| JP2016522254A5 (enExample) | ||
| PH12018502445A1 (en) | Compositions and methods for treating negative symptoms in non-schizophrenic patients | |
| JP2017533220A5 (enExample) | ||
| EA201990664A1 (ru) | Производные 5-[2-(пиридин-2-иламино)-1,3-тиазол-5-ил]-2,3-дигидро-1h-изоиндол-1-она и их применение в качестве двойных ингибиторов фосфатидилинозитол-3-киназ дельта и гамма |